Vulvodynia: The Role of Inflammation in the Etiology of Localized Provoked Pain of the Vulvar Vestibule (Vestibulodynia)

Seminars in Reproductive Medicine

Volumn 33, Issue 4, 2015, Pages 239-245

  Akopians, Alin L ^a   Rapkin, Andrea J ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

inflammation; localized provoked vulvodynia; vestibulodynia; vulvodynia

Indexed keywords

ALLERGIC REACTION; ARTICLE; CANDIDA ALBICANS; COMORBIDITY; FEMALE; FIBROBLAST; GENETIC POLYMORPHISM; HORMONAL CONTRACEPTION; HUMAN; IMMUNE SYSTEM; IMMUNOPATHOLOGY; IN VITRO STUDY; LOCALIZED PROVOKED VULVODYNIA; MAST CELL; MENOPAUSE; NERVE ENDING; NERVOUS SYSTEM INFLAMMATION; NONHUMAN; SOCIAL PSYCHOLOGY; VAGINITIS; VESTIBULODYNIA; VULVODYNIA; COMPLICATION; INFLAMMATION; PATHOLOGY; PELVIC PAIN;

FEMALE; HUMANS; INFLAMMATION; PELVIC PAIN; VULVODYNIA;

EID: 84934279882     PISSN: 15268004     EISSN: 15264564     Source Type: Journal    
DOI: 10.1055/s-0035-1554919     Document Type: Article

References (75)

1. Moyal-Barracco M., Lynch P. J. 2003 ISSVD terminology and classification of vulvodynia: a historical perspective. J Reprod Med: 2004; 49 10 772 777
2. McKay M. Vulvodynia. A multifactorial clinical problem. Arch Dermatol: 1989; 125 2 256 262
3. Friedrich E. G. Jr. Vulvar vestibulitis syndrome. J Reprod Med: 1987; 32 2 110 114
4. Young A. W. Burning vulva syndrome: report of the ISSVD task force. J Reprod Med: 1984; 29 457
5. Friedrich E. G. Jr. The vulvar vestibule. J Reprod Med: 1983; 28 11 773 777
6. Woodruff J. D., Friedrich E. G. Jr. The vestibule. Clin Obstet Gynecol: 1985; 28 1 134 141
7. Slone S., Reynolds L., Gall S., et al. Localization of chromogranin, synaptophysin, serotonin, and CXCR2 in neuroendocrine cells of the minor vestibular glands: an immunohistochemical study. Int J Gynecol Pathol: 1999; 18 4 360 365
8. Lundqvist E. N., Hofer P. A., Olofsson J. I., Sjöberg I. Is vulvar vestibulitis an inflammatory condition? A comparison of histological findings in affected and healthy women. Acta Derm Venereol: 1997; 77 4 319 322
9. Bohm-Starke N., Hilliges M., Brodda-Jansen G., Rylander E., Torebjörk E. Psychophysical evidence of nociceptor sensitization in vulvar vestibulitis syndrome. Pain: 2001; 94 2 177 183
10. Leclair C. M., Goetsch M. F., Korcheva V. B., Anderson R., Peters D., Morgan T. K. Differences in primary compared with secondary vestibulodynia by immunohistochemistry. Obstet Gynecol: 2011; 117 6 1307 1313
11. Edwards L. New concepts in vulvodynia. Am J Obstet Gynecol: 2003; 189 (3, Suppl): S24 S30
12. Reed B. D., Cantor L. E. Vulvodynia in preadolescent girls. J Low Genit Tract Dis: 2008; 12 4 257 261
13. Clare C. A., Yeh J. Vulvodynia in adolescence: childhood vulvar pain syndromes. J Pediatr Adolesc Gynecol: 2011; 24 3 110 115
14. Goetsch M. F. Vulvar vestibulitis: prevalence and historic features in a general gynecologic practice population. Am J Obstet Gynecol: 1991; 164 6, Pt 1 1609 1614, discussion 1614-1616
15. Harlow B. L., Stewart E. G. A population-based assessment of chronic unexplained vulvar pain: have we underestimated the prevalence of vulvodynia? J Am Med Womens Assoc: 2003; 58 2 82 88
16. Reed B. D., Harlow S. D., Sen A., et al. Prevalence and demographic characteristics of vulvodynia in a population-based sample. Am J Obstet Gynecol: 2012; 206 2 170.e1 9
17. Xie Y., Shi L., Xiong X., Wu E., Veasley C., Dade C. Economic burden and quality of life of vulvodynia in the United States. Curr Med Res Opin: 2012; 28 4 601 608
18. Nguyen R. H., Mathur C., Wynings E. M., Williams D. A., Harlow B. L. Remission of vulvar pain among women with primary vulvodynia. J Low Genit Tract Dis: 2015; 19 1 62 67
19. Bachmann G. A., Rosen R., Pinn V. W., et al. Vulvodynia: a state-of-the-art consensus on definitions, diagnosis and management. J Reprod Med: 2006; 51 6 447 456
20. Nguyen R. H., Ecklund A. M., Maclehose R. F., Veasley C., Harlow B. L. Co-morbid pain conditions and feelings of invalidation and isolation among women with vulvodynia. Psychol Health Med: 2012; 17 5 589 598
21. Nguyen R. H., Veasley C., Smolenski D. Latent class analysis of comorbidity patterns among women with generalized and localized vulvodynia: preliminary findings. J Pain Res: 2013; 6 303 309
22. Sarton J. Assessment of the pelvic floor muscles in women with sexual pain. J Sex Med: 2010; 7 11 3526 3529
23. Wesselmann U., Bonham A., Foster D. Vulvodynia: Current state of the biological science. Pain: 2014; 155 9 1696 1701
24. Feldhaus-Dahir M. The causes and prevalence of vestibulodynia: a vulvar pain disorder. Urol Nurs: 2011; 31 1 51 54
25. Nyirjesy P. Vulvar vestibulitis syndrome: a post-infectious entity? Curr Infect Dis Rep: 2000; 2 6 531 535
26. Turner M. L., Marinoff S. C. Association of human papillomavirus with vulvodynia and the vulvar vestibulitis syndrome. J Reprod Med: 1988; 33 6 533 537
27. Pathak D., Agrawal S., Dhali T. K. Prevalences of and risk factors for vulvar diseases in Nepal: a hospital-based study. Int J Dermatol: 2011; 50 2 161 167
28. Nguyen R. H., Swanson D., Harlow B. L. Urogenital infections in relation to the occurrence of vulvodynia. J Reprod Med: 2009; 54 6 385 392
29. Ramirez D. E., Knott H. M., McCormick T. S., et al. Cutaneous hypersensitivity to Candida albicans in idiopathic vulvodynia. Contact Dermatitis: 2005; 53 4 214 218
30. Edgardh K., Abdelnoor M. Vulvar vestibulitis and risk factors: a population-based case-control study in Oslo. Acta Derm Venereol: 2007; 87 4 350 354
31. Jayaram A., Witkin S. S., Zhou X., et al. The bacterial microbiome in paired vaginal and vestibular samples from women with vulvar vestibulitis syndrome. Pathog Dis: 2014; 72 3 161 166
32. Farmer M. A., Taylor A. M., Bailey A. L., et al. Repeated vulvovaginal fungal infections cause persistent pain in a mouse model of vulvodynia. Sci Transl Med: 2011; 3 101 101ra91
33. Ventolini G., Gygax S. E., Adelson M. E., Cool D. R. Vulvodynia and fungal association: a preliminary report. Med Hypotheses: 2013; 81 2 228 230
34. Foster D. C., Falsetta M. L., Woeller C. F., et al. Site-specific mesenchymal control of inflammatory pain to yeast challenge in vulvodynia-afflicted and pain-free women. Pain: 2015; 156 3 386 396
35. Foster D. C., Hasday J. D. Elevated tissue levels of interleukin-1 beta and tumor necrosis factor-alpha in vulvar vestibulitis. Obstet Gynecol: 1997; 89 2 291 296
36. Gerber S., Bongiovanni A. M., Ledger W. J., Witkin S. S. Defective regulation of the proinflammatory immune response in women with vulvar vestibulitis syndrome. Am J Obstet Gynecol: 2002; 186 4 696 700
37. Chadha S., Gianotten W. L., Drogendijk A. C., Weijmar Schultz W. C., Blindeman L. A., van der Meijden W. I. Histopathologic features of vulvar vestibulitis. Int J Gynecol Pathol: 1998; 17 1 7 11
38. Foster D. C., Piekarz K. H., Murant T. I., et al. Enhanced synthesis of proinflammatory cytokines by vulvar vestibular fibroblasts: implications for vulvar vestibulitis. Am J Obstet Gynecol: 2007; 196 4 346.e1 8
39. Cunha F. Q., Poole S., Lorenzetti B. B., Ferreira S. H. The pivotal role of tumour necrosis factor alpha in the development of inflammatory hyperalgesia. Br J Pharmacol: 1992; 107 3 660 664
40. Eliav E., Benoliel R., Herzberg U., Kalladka M., Tal M. The role of IL-6 and IL-1beta in painful perineural inflammatory neuritis. Brain Behav Immun: 2009; 23 4 474 484
41. Firestein G. S., Alvaro-Gracia J. M., Maki R. Quantitative analysis of cytokine gene expression in rheumatoid arthritis. J Immunol: 1990; 144 9 3347 3353
42. Daymond T. J., Rowell F. J. Reduction of prostaglandin E2 concentrations in synovial fluid of patients suffering from rheumatoid arthritis following tiaprofenic acid or indomethacin treatment. Drugs: 1988; 35 01 4 8
43. Zanjani T. M., Sabetkasaei M., Mosaffa N., Manaheji H., Labibi F., Farokhi B. Suppression of interleukin-6 by minocycline in a rat model of neuropathic pain. Eur J Pharmacol: 2006; 538 1-3 66 72
44. Falsetta M. L., Foster D. C., Woeller C. F., et al. Identification of novel mechanisms involved in generating localized vulvodynia pain. Am J Obstet Gynecol: 2015;; Epub ahead of print
45. Gerber S., Bongiovanni A. M., Ledger W. J., Witkin S. S. Interleukin-1beta gene polymorphism in women with vulvar vestibulitis syndrome. Eur J Obstet Gynecol Reprod Biol: 2003; 107 1 74 77
46. Jeremias J., Ledger W. J., Witkin S. S. Interleukin 1 receptor antagonist gene polymorphism in women with vulvar vestibulitis. Am J Obstet Gynecol: 2000; 182 2 283 285
47. Babula O., Danielsson I., Sjoberg I., Ledger W. J., Witkin S. S. Altered distribution of mannose-binding lectin alleles at exon I codon 54 in women with vulvar vestibulitis syndrome. Am J Obstet Gynecol: 2004; 191 3 762 766
48. Babula O., Linhares I. M., Bongiovanni A. M., et al. Association between primary vulvar vestibulitis syndrome, defective induction of tumor necrosis factor-alpha, and carriage of the mannose-binding lectin codon 54 gene polymorphism. Am J Obstet Gynecol: 2008; 198 1 101.e1 4
49. Foster D. C., Sazenski T. M., Stodgell C. J. Impact of genetic variation in interleukin-1 receptor antagonist and melanocortin-1 receptor genes on vulvar vestibulitis syndrome. J Reprod Med: 2004; 49 7 503 509
50. Gerber S., Witkin S. S., Stucki D. Immunological and genetic characterization of women with vulvodynia. J Med Life: 2008; 1 4 432 438
51. Witkin S. S., Gerber S., Ledger W. J. Differential characterization of women with vulvar vestibulitis syndrome. Am J Obstet Gynecol: 2002; 187 3 589 594
52. Summerfield J. A., Sumiya M., Levin M., Turner M. W. Association of mutations in mannose binding protein gene with childhood infection in consecutive hospital series. BMJ: 1997; 314 7089 1229 1232
53. Garred P., Madsen H. O., Halberg P., et al. Mannose-binding lectin polymorphisms and susceptibility to infection in systemic lupus erythematosus. Arthritis Rheum: 1999; 42 10 2145 2152
54. Tympanidis P., Terenghi G., Dowd P. Increased innervation of the vulval vestibule in patients with vulvodynia. Br J Dermatol: 2003; 148 5 1021 1027
55. Tympanidis P., Casula M. A., Yiangou Y., Terenghi G., Dowd P., Anand P. Increased vanilloid receptor VR1 innervation in vulvodynia. Eur J Pain: 2004; 8 2 129 133
56. Donders G., Bellen G. Characteristics of the pain observed in the focal vulvodynia syndrome (VVS). Med Hypotheses: 2012; 78 1 11 14
57. Bergeron S., Binik Y. M., Khalifé S., Pagidas K., Glazer H. I. Vulvar vestibulitis syndrome: reliability of diagnosis and evaluation of current diagnostic criteria. Obstet Gynecol: 2001; 98 1 45 51
58. Bohm-Starke N., Falconer C., Rylander E., Hilliges M. The expression of cyclooxygenase 2 and inducible nitric oxide synthase indicates no active inflammation in vulvar vestibulitis. Acta Obstet Gynecol Scand: 2001; 80 7 638 644
59. Pukall C. F., Binik Y. M., Khalifé S., Amsel R., Abbott F. V. Vestibular tactile and pain thresholds in women with vulvar vestibulitis syndrome. Pain: 2002; 96 1-2 163 175
60. Sonni L., Cattaneo A., De Marco A., De Magnis A., Carli P., Marabini S. Idiopathic vulvodynia. Clinical evaluation of the pain threshold with acetic acid solutions. J Reprod Med: 1995; 40 5 337 341
61. Zolnoun D., Bair E., Essick G., Gracely R., Goyal V., Maixner W. Reliability and reproducibility of novel methodology for assessment of pressure pain sensitivity in pelvis. J Pain: 2012; 13 9 910 920
62. Turner M. L., Marinoff S. C. Pudendal neuralgia. Am J Obstet Gynecol: 1991; 165 4, Pt 2 1233 1236
63. Foster D. C., Dworkin R. H., Wood R. W. Effects of intradermal foot and forearm capsaicin injections in normal and vulvodynia-afflicted women. Pain: 2005; 117 1-2 128 136
64. Ledger W. J., Kessler A., Leonard G. H., Witkin S. S. Vulvar vestibulitis-a complex clinical entity. Infect Dis Obstet Gynecol: 1996; 4 5 269 275
65. Babula O., Bongiovanni A. M., Ledger W. J., Witkin S. S. Immunoglobulin E antibodies to seminal fluid in women with vulvar vestibulitis syndrome: relation to onset and timing of symptoms. Am J Obstet Gynecol: 2004; 190 3 663 667
66. Harlow B. L., Vitonis A. F., Stewart E. G. Influence of oral contraceptive use on the risk of adult-onset vulvodynia. J Reprod Med: 2008; 53 2 102 110
67. Bohm-Starke N., Johannesson U., Hilliges M., Rylander E., Torebjörk E. Decreased mechanical pain threshold in the vestibular mucosa of women using oral contraceptives: a contributing factor in vulvar vestibulitis? J Reprod Med: 2004; 49 11 888 892
68. Bouchard C., Brisson J., Fortier M., Morin C., Blanchette C. Use of oral contraceptive pills and vulvar vestibulitis: a case-control study. Am J Epidemiol: 2002; 156 3 254 261
69. Johannesson U., Blomgren B., Hilliges M., Rylander E., Bohm-Starke N. The vulval vestibular mucosa-morphological effects of oral contraceptives and menstrual cycle. Br J Dermatol: 2007; 157 3 487 493
70. Eva L. J., MacLean A. B., Reid W. M., Rolfe K. J., Perrett C. W. Estrogen receptor expression in vulvar vestibulitis syndrome. Am J Obstet Gynecol: 2003; 189 2 458 461
71. Johannesson U., Sahlin L., Masironi B., et al. Steroid receptor expression and morphology in provoked vestibulodynia. Am J Obstet Gynecol: 2008; 198 3 311.e1 6
72. Griebling T. L., Liao Z., Smith P. G. Systemic and topical hormone therapies reduce vaginal innervation density in postmenopausal women. Menopause: 2012; 19 6 630 635
73. Bergeron S., Likes W. M., Steben M. Psychosexual aspects of vulvovaginal pain. Best Pract Res Clin Obstet Gynaecol: 2014; 28 7 991 999
74. Khandker M., Brady S. S., Stewart E. G., Harlow B. L. Is chronic stress during childhood associated with adult-onset vulvodynia? J Womens Health (Larchmt): 2014; 23 8 649 656
75. Seckin-Alac E., Akhant S. E., Bastu E., Tuzlalik S., Yavuz E. Elevated tissue levels of tumor necrosis factor-α in vulvar vestibulitis syndrome. Clin Exp Obstet Gynecol: 2014; 41 6 691 693